Ozempic could slow down ageing researchers suggest
The anti-obesity drug Ozempic could slow down ageing and has “far-reaching benefits” beyond what was imagined, researchers have suggested. Multiple studies have found semaglutide (available under the brand names Wegovy and Ozempic) reduced the risk of death in people who were obese or overweight and had cardiovascular disease without diabetes. Participants who took semaglutide died at a lower rate from all causes, as well from cardiovascular causes and Covid-19, researchers […]